By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


 

Merrimack Pharmaceuticals Inc. 

101 Binney Street

Cambridge  Massachusetts  02142  U.S.A.
Phone: 617-441-1000 Fax: 617-491-1386


SEARCH JOBS



Segment
Start Up

Collaborations

Dyax Corp.  Antibody phage display





Company News
Merrimack (MACK) And Baxter BioScience Corporation (BAX) Announce Completion Of New Drug Application Submission To U.S. FDA For MM-398 As A Treatment For Post-Gemcitabine Metastatic Pancreatic Cancer 4/27/2015 6:53:49 AM
Merrimack (MACK) Release: First-in-Human Phase 1 Trial Of MM-141 Demonstrates Activity In Biomarker Positive Patients 4/21/2015 11:28:40 AM
Merrimack (MACK) Announces Final Clinical Results For MM-302 Phase 1 Study Demonstrating Robust Activity In Heavily Pre-Treated Patients With HER2-Positive Metastatic Breast Cancer 4/21/2015 9:49:29 AM
Merrimack (MACK) To Highlight Extensive Oncology Pipeline At The 2015 American Association for Cancer Research Annual Meeting 3/26/2015 1:23:35 PM
1,075 New Jobs to be Added by 11 Life Science Firms in Massachusetts: Amgen (AMGN), Alnylam (ALNY), Biogen Idec, Inc. (North Carolina) (BIIB), GE Healthcare Bio-Sciences, Quest Diagnostics (DGX), Alkermes (ALKS), Baxter Healthcare (BAX), Merrimack (MACK), Synageva BioPharma (GEVA), Philips Electronics, SMC 3/19/2015 6:51:59 AM
Advanced Cell Diagnostics, Inc.' RNAscope Technology Supports Biomarker-Selected Phase 2 Clinical Trial Of Merrimack Pharmaceuticals Inc. (MACK)' MM-121 3/9/2015 6:36:47 AM
Merrimack Pharmaceuticals Inc. (MACK) Reports Fourth Quarter 2014 Financial Results 2/26/2015 1:22:04 PM
Merrimack Pharmaceuticals Inc. (MACK) Announces Initiation Of A Phase 2 Biomarker-Selected Clinical Trial Of MM-121 In Patients With Heregulin Positive Non-Small Cell Lung Cancer 2/19/2015 7:35:36 AM
Merrimack Pharmaceuticals Inc. (MACK) Announces Timing Of Fourth Quarter 2014 Investor Conference Call 2/12/2015 7:49:15 AM
Merrimack Pharmaceuticals Inc. (MACK) Names Birgit M. Schoeberl, Ph.D. As Head Of Discovery Division And Announces The Addition Of Ulrik B. Nielsen, Ph.D. To Its Board Of Directors 1/23/2015 7:39:11 AM
12345678910...
//-->